Skip to content

Opening book details…

Can I read Risk factors for difficult‐to‐treat hepatitis C virus genotype 4r in Rwanda and implications for elimination in sub‐Saharan Africa on EtoBox?

Risk factors for difficult‐to‐treat hepatitis C virus genotype 4r in Rwanda and implications for elimination in sub‐Saharan Africa by Fabienne Shumbusho; Anne F. Liu; Fredrick Kateera; Jules Kabahizi; Sabin Nsanzaimana; Janvier Serumondo; Jean Damascene Makuza; Philip M. Grant; Emmanuel Musabeyezu; Claude Muvunyi; Neil Gupta is a Medicine article available to read on EtoBox.

What is Risk factors for difficult‐to‐treat hepatitis C virus genotype 4r in Rwanda and implications for elimination in sub‐Saharan Africa about?

In sub-Saharan Africa, there exist distinct HCV genotype (GT) subtypes harbouring resistance-associated substitutions to commonly used non-structural protein 5A (NS5A) inhibitor-based direct-acting antiviral (DAA) regimens. In particular, GT4r subtype has demonstrated high rates of treatment failure. In the absence of routine viral sequencing in sub-Saharan Africa, it is important to identify sociodemographic, epidemiologic, and clinical characteristics that may be associated with GT4r infection. Methods: A secondary analysis was performed on data from 300 adults with HCV GT4 enrolled in a prospective trial assessing the safety and efficacy of sofosbuvir-ledipasvir in Rwanda in 2017. The association between characteristics at enrolment and GT subtype was assessed by chi-square analysis and logistic regression. In multivariate analysis, there were a higher proportion of participants with GT4r subtype with age 1 million IU/ml (OR: 3.4, 95% CI: 1.6-6.9, p = 0.001). Rwandan adults with GT4r are more likely to be younger, have a history of hospital admissions and surgeries and have more active or advanced liver disease compared to those with other GT4 subtypes. In the absence of advanc

Who reads Risk factors for difficult‐to‐treat hepatitis C virus genotype 4r in Rwanda and implications for elimination in sub‐Saharan Africa?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Fabienne Shumbusho; Anne F. Liu; Fredrick Kateera; Jules Kabahizi; Sabin Nsanzaimana; Janvier Serumondo; Jean Damascene Makuza; Philip M. Grant; Emmanuel Musabeyezu; Claude Muvunyi; Neil Gupta
Publisher
Wiley
Published
2021
Language
EN
Field
Medicine (Health Sciences)

More by Fabienne Shumbusho; Anne F. Liu; Fredrick Kateera; Jules Kabahizi; Sabin Nsanzaimana; Janvier Serumondo; Jean Damascene Makuza; Philip M. Grant; Emmanuel Musabeyezu; Claude Muvunyi; Neil Gupta

Browse all works by Fabienne Shumbusho; Anne F. Liu; Fredrick Kateera; Jules Kabahizi; Sabin Nsanzaimana; Janvier Serumondo; Jean Damascene Makuza; Philip M. Grant; Emmanuel Musabeyezu; Claude Muvunyi; Neil Gupta